Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Evaluation of Extensively Hydrolyzed Formula for Cow's Milk Protein Allergy (CMPA) in Infants and Young Children

NCT07484035 is registered in ClinicalTrials.gov with Heilongjiang Feihe Dairy Co. Ltd. as lead sponsor.

NCT NCT07484035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07484035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Evaluation of Extensively Hydrolyzed Formula for Cow's Milk Protein Allergy (CMPA) in Infants and Young Children
Lead sponsor
Heilongjiang Feihe Dairy Co. Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 5, 2026
Completion date
July 31, 2026
Enrollment
124 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cow's milk protein allergy (cmpa)